BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31740490)

  • 1. Highly Contingent Phenotypes of Lon Protease Deficiency in Escherichia coli upon Antibiotic Challenge.
    Matange N
    J Bacteriol; 2020 Jan; 202(3):. PubMed ID: 31740490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical principles predict fitness landscapes of drug resistance.
    Rodrigues JV; Bershtein S; Li A; Lozovsky ER; Hartl DL; Shakhnovich EI
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):E1470-8. PubMed ID: 26929328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of a quality control protease in
    Thompson S; Zhang Y; Ingle C; Reynolds KA; Kortemme T
    Elife; 2020 Jul; 9():. PubMed ID: 32701056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trade-offs with stability modulate innate and mutationally acquired drug resistance in bacterial dihydrofolate reductase enzymes.
    Matange N; Bodkhe S; Patel M; Shah P
    Biochem J; 2018 Jun; 475(12):2107-2125. PubMed ID: 29871875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of Lon protease and its substrate MarA during sodium salicylate-mediated growth reduction and antibiotic resistance in Escherichia coli.
    Bhaskarla C; Das M; Verma T; Kumar A; Mahadevan S; Nandi D
    Microbiology (Reading); 2016 May; 162(5):764-776. PubMed ID: 26944926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
    Nicoloff H; Perreten V; Levy SB
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1293-303. PubMed ID: 17220404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lon protease inactivation, or translocation of the lon gene, potentiate bacterial evolution to antibiotic resistance.
    Nicoloff H; Andersson DI
    Mol Microbiol; 2013 Dec; 90(6):1233-48. PubMed ID: 24325250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation and compensation in a bacterial gene regulatory network evolving under antibiotic selection.
    Patel V; Matange N
    Elife; 2021 Sep; 10():. PubMed ID: 34591012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two new mutations in dnaJ suppress DNA damage hypersensitivity and capsule overproduction phenotypes of Δlon mutant of Escherichia coli by modulating the expression of clpYQ (hslUV) and rcsA genes.
    Kumaran NAM; Karthik M; Kumar V; Jebasingh T; Munavar MH
    Gene; 2020 Feb; 726():144135. PubMed ID: 31589958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trimethoprim derivative impedes antibiotic resistance evolution.
    Manna MS; Tamer YT; Gaszek I; Poulides N; Ahmed A; Wang X; Toprak FCR; Woodard DR; Koh AY; Williams NS; Borek D; Atilgan AR; Hulleman JD; Atilgan C; Tambar U; Toprak E
    Nat Commun; 2021 May; 12(1):2949. PubMed ID: 34011959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SulA-dependent hypersensitivity to high pressure and hyperfilamentation after high-pressure treatment of Escherichia coli lon mutants.
    Aertsen A; Michiels CW
    Res Microbiol; 2005 Mar; 156(2):233-7. PubMed ID: 15748989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein quality control acts on folding intermediates to shape the effects of mutations on organismal fitness.
    Bershtein S; Mu W; Serohijos AW; Zhou J; Shakhnovich EI
    Mol Cell; 2013 Jan; 49(1):133-44. PubMed ID: 23219534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of disruption of heat shock genes on susceptibility of Escherichia coli to fluoroquinolones.
    Yamaguchi Y; Tomoyasu T; Takaya A; Morioka M; Yamamoto T
    BMC Microbiol; 2003 Aug; 3():16. PubMed ID: 12911840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased substrate affinity in the Escherichia coli L28R dihydrofolate reductase mutant causes trimethoprim resistance.
    Abdizadeh H; Tamer YT; Acar O; Toprak E; Atilgan AR; Atilgan C
    Phys Chem Chem Phys; 2017 May; 19(18):11416-11428. PubMed ID: 28422217
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mohiuddin SG; Massahi A; Orman MA
    mBio; 2022 Feb; 13(1):e0218721. PubMed ID: 35038905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of organic solvent tolerance by disruption of the lon gene in Escherichia coli.
    Watanabe R; Doukyu N
    J Biosci Bioeng; 2014 Aug; 118(2):139-44. PubMed ID: 24571965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Trimethoprim Resistance Gene,
    Wüthrich D; Brilhante M; Hausherr A; Becker J; Meylan M; Perreten V
    mSphere; 2019 May; 4(3):. PubMed ID: 31068437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integron-Associated DfrB4, a Previously Uncharacterized Member of the Trimethoprim-Resistant Dihydrofolate Reductase B Family, Is a Clinically Identified Emergent Source of Antibiotic Resistance.
    Toulouse JL; Edens TJ; Alejaldre L; Manges AR; Pelletier JN
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB.
    Nicoloff H; Perreten V; McMurry LM; Levy SB
    J Bacteriol; 2006 Jun; 188(12):4413-23. PubMed ID: 16740948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques.
    Vickers AA; Potter NJ; Fishwick CW; Chopra I; O'Neill AJ
    J Antimicrob Chemother; 2009 Jun; 63(6):1112-7. PubMed ID: 19383727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.